$ABX

Abacus (ABX) Q2 2026 Earnings Call Transcript

Abacus Global Management (ABX) reported Q2 2026 revenue of $73.0 million, up 30% year over year, driven by Life Solutions. Adjusted net income was $27.1 million (+24%) and adjusted EPS $0.28 (+22%). Adjusted EBITDA was $39.9 million with a 54.7% margin. The company reiterated full-year guidance of $100 million to $106 million adjusted net income and $1.00 to $1.05 EPS.

Original reporting
Published Aug 14, 2026, 5:15 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 14, 2026, 5:30 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Abacus (ABX) Q2 2026 Earnings Call Transcript — source image
Decision brief

The 30-second read

$ABXBullishMed
01

Why it matters

Traders can update expectations for Q3 and full-year profitability based on reiterated guidance and the stated risk of fee headwinds from non-longevity AUM declines.

02

Market read

A company-specific earnings and guidance update with quantified segment growth, AUM and cash flow metrics, and a clear stated offset from ETF AUM outflows.

03

What to watch

Tokenization of in-force policies and interval fund launch are strategic, but the article does not quantify near-term revenue impact from these initiatives beyond general platform build-out.

Relevance 8/10Novelty 8/10Timing: earnings call released Aug. 6, 2026 (Q2 results and Q3 guidance)

Background

Abacus Global Management held its Q2 2026 earnings call, emphasizing longevity-linked revenue growth, LifeARC technology integration, and a shift toward fee-related earnings.

Company-level read

Ticker impact

$ABXBullishMedium confidence
Context

Abacus reported Q2 2026 revenue of $73.0M, adjusted EPS $0.28, and reiterated full-year adjusted EPS guidance of $1.00 to $1.05.

Expected impact

Likely modest positive bias for ABX on earnings-day positioning, with volatility risk tied to non-longevity AUM outflows.

Evidence & confidence

The article provides concrete earnings metrics, Q3 and full-year guidance ranges, and a specific risk driver (lower ETF fees from AUM decline) that can temper upside.

Market effects

Highlights growth in longevity-linked finance and technology platform adoption, while also flagging fee sensitivity to ETF AUM outflows.

No clear regional transmission beyond US-listed earnings dynamics.

Limited, as the disclosures are company-specific and not tied to global macro policy.

Counterpoint

The company beat Q2 targets, but management explicitly cites lower asset management fees from declining ETF AUM, suggesting the quality of growth may be uneven across segments.

Key entities

  • Abacus Global Management

    Reported Q2 2026 results, reiterated 2026 guidance, and discussed longevity platform growth plus ETF fee headwinds.

  • Manning & Napier Investment

    Announced as a minority equity stake partner, creating a referral channel and alliance.

  • LifeARC

    Proprietary data and technology platform referenced as enabling personalized longevity modeling and mortality verification.

Related articles

$ABXMed

Daily Special: Dimerix, Astral Resources, Midas Minerals, ABx Group, OncoSil Medical

Australian shares fell at midday, with the S&P/ASX 200 down 0.28% to 9,089.40. Sector weakness was led by consumer discretionary, while banks and tech also declined. In small caps, Dimerix gained full US IND control for DMX-652, Astral expanded Theia Deeps drilling, Midas extended Spaatzu copper-silver results, ABx advanced Sunrise approvals, and OncoSil received US FDA approval.

$ABXMedAI 8/10

Abacus Global Management (ABX) unveils $100 million share repurchase through 2028

Abacus Global Management (NYSE: ABX) said its board authorized a $100 million share repurchase program starting Aug. 17, 2026, running until May 6, 2028. Purchases may be made in open market or negotiated transactions, including accelerated repurchases and Rule 10b5-1 plans. The company cited about $80 million repurchased under prior programs since Dec. 2023.

$ABXMed

Barrick names Bock to lead overseas arm ahead of split

Barrick Mining named Sebastiaan Bock to lead its Rest of World division, overseeing international gold and copper operations in Africa, the Middle East, Latin America and Asia Pacific. Barrick said the unit produces over 2 million gold-equivalent ounces annually and expects output to rise more than 20% over three years. The appointment follows a settlement with Newmont: $1.95 billion cash and consent to Barrick’s planned North America IPO by year-end.